NEUROGT INC

Creating futures through transformative science and sustainable vision.

Durham, United States · Founded 2020 · $1.3M raised

Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$1.3M
Last Round
$307K GrantAug 2023
Rounds
3

About

NeuroGT is a clinical-stage gene therapy company targeting rare neurogenetic diseases affecting the central nervous system and metabolic pathways. Its platform includes AAV9 gene replacement therapy, Antibody Cleaver (AbC) technology for enabling re-dosing, and AAV-mediated extracellular vesicle mRNA delivery. The company focuses on lysosomal storage disorders including Hurler, Hunter, and Sanfilippo syndromes.

Summary

NEUROGT INC is a Biotech company based in Durham, United States, founded in 2020. It has raised $1.3M in total across 3 rounds, most recently a $307K Grant round in Aug 2023. Investors include National Institutes of Health and National Institute of Allergy and Infectious Diseases.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantAug 2023
$307K

Sign up to see all 3 rounds

Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NEUROGT INC on Indexed.vc
<a href="https://indexed.vc/companies/neurogt-inc"><img src="https://indexed.vc/api/badge/company/neurogt-inc" alt="NEUROGT INC on Indexed.vc" width="260" height="76" /></a>